Foghorn Therapeutics Inc. ( FHTX) - Key Metrics
FHTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.15 | -$0.34 | -$0.35 | -$0.35 |
| 2025Q3 | $0.13 | -$0.25 | -$0.30 | -$0.30 |
| 2025Q2 | $0.12 | -$0.28 | -$0.33 | -$0.33 |
| 2025Q1 | $0.09 | -$0.30 | -$0.38 | -$0.38 |
FHTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -3.92 |
| 2025Q3 | ? | -4.86 |
| 2025Q2 | ? | -4.13 |
| 2025Q1 | ? | -3.04 |
FHTX
Price: $4.01
52 week price:
Earnings Per Share: -1.17 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 18512
Market Capitalization: 219.0 million